Skip to content
DataLookout
Start free
Menu

NCT07639866

Combination of CXD and Restrictive Ketogenic Diet Against MASLD

StatusNot Yet Recruiting
PhasePhase 2
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Start date: Jun 1, 2026 to Jul 1, 2026v2
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Controlled Attenuation Parameter (CAP) value
Timeframe: From enrollment to the end of treatment at 8 weeks

Secondary (12)

BMI
Triglyceride(TG)
Total blood cholesterol(TC)
High-Density Lipoprotein(HDL)
Alanine Aminotransferase (ALT)
Show 7 moreShow less
Aspartate Aminotransferase(AST)
Gamma-Glutamyl Transferase(GGT)
Blood glucose metabolism indicators
Traditional Chinese Medicine Syndrome Scoring System
Blood ketones
Creatinine
Blood Urea Nitrogen

Arms and interventions

Low-carbon control groupPlacebo comparator
KD groupExperimental
CXD and KD groupExperimental

Dietary supplements: Low-carbon control group, KD group

Drugs: CXD and KD group